Cover Image

Comparative efficacy of different Chinese patent medicines in preventing restenosis after percutaneous coronary intervention: a systematic review and Bayesian network meta-analysis of randomized clinical trials

Background: Chinese patent medicines (CMPs) have curative effectiveness in preventing coronary restenosis. However, the relative efficacy between different CPMs has not been sufficiently investigated.Methods: Randomized clinical trials were searched from electronic databases including PubMed, Web of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jiasai Fan (Author), Tianli Li (Author), Fenglan Pu (Author), Nan Guo (Author), Jing Wang (Author), Yuqian Gao (Author), Hongbing Zhao (Author), Xian Wang (Author), Haiyan Zhu (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention
by: Dedi Wihanda, et al.
Published: (2015)

Serum Homocysteine Level Predictive Capability for Severity of Restenosis Post Percutaneous Coronary Intervention
by: Jiqiang Guo, et al.
Published: (2022)

DETECTING PAINLESS MYOCARDIAL ISCHEMIA IN A PATIENT WITH RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION
by: M. A. Elkanova, et al.
Published: (2016)

Albumin to globulin ratio was associated with in‐stent restenosis and revascularization events after percutaneous coronary intervention
by: Rui Zhang, et al.
Published: (2022)

Analysis of influencing factors for restenosis after percutaneous transluminal angioplasty in hemodialysis patients
by: Shen Zhan, et al.
Published: (2024)

Changes of miR-130a and ET-1 and Their Predictive Value for In-Stent Restenosis after Percutaneous Coronary Intervention
by: Hongliang LIU, et al.
Published: (2020)

Relationship between the extent of coronary artery disease and in-stent restenosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Erkan Yıldırım, et al.
Published: (2017)

Comparative efficacy of Chinese patent medicines in patients with carotid atherosclerotic plaque: a Bayesian network meta− analysis
by: Wenquan Su, et al.
Published: (2023)

Cardioprotective effects of curcumin against myocardial I/R injury: A systematic review and meta-analysis of preclinical and clinical studies
by: Tianli Li, et al.
Published: (2023)

Gene Therapy for the Prevention of in- Stent Restenosis Post Coronary Angioplasty
by: P Ranjzad, et al.
Published: (2005)

Gene Therapy for the Prevention of in- Stent Restenosis Post Coronary Angioplasty
by: P Ranjzad, et al.
Published: (2005)

Comparative efficacy of seven Chinese patent medicines for early diabetic kidney disease: A Bayesian network meta-analysis
by: Jie Zhao, et al.
Published: (2022)

Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysis
by: Dan Zhang, et al.
Published: (2020)

Nanoparticle-based approaches for treating restenosis after vascular injury
by: Liangfeng Zhao, et al.
Published: (2024)

Mechanistic exploration of Yiqi Liangxue Shengji prescription on restenosis after balloon injury by integrating metabolomics with network pharmacology
by: Tianshi Mao, et al.
Published: (2023)

Comparative Efficacy of Oral Chinese Patent Medicine for Chronic Prostatitis/Chronic Pelvic Pain Syndrome With Sexual Dysfunction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
by: Yang Zhang, et al.
Published: (2021)

Bayesian network analysis of factors influencing type 2 diabetes, coronary heart disease, and their comorbidities
by: Danli Kong, et al.
Published: (2024)

Factores predictivos de la reestenosis mitral posvalvuloplastia mitral percutánea. Mitral restenosis in percutaneous mitral valvuloplasty. The predictive factors.
by: Juan Valiente Mustelier, et al.
Published: (2010)

Bayesian Networks
Published: (2012)

Bayesian Network
Published: (2010)

Impact of Thrombocytopenia on In-Hospital Outcome in Patients Undergoing Percutaneous Coronary Intervention
by: Zhongxiu Chen, et al.
Published: (2021)

Stress and Vascular Responses: Anti-inflammatory Therapeutic Strategy Against Atherosclerosis and Restenosis After Coronary Intervention
by: Shiro Kitamoto, et al.
Published: (2003)

Variables asociadas a reestenosis clínica en pacientes con intervencionismo coronario percutáneo con stent convencional. Variables related to clinic restenosis in patients after percutaneous coronary interventionism with conventional stent.
by: Liz Álvarez González, et al.
Published: (2011)

Machine learning for prediction of bleeding in acute myocardial infarction patients after percutaneous coronary intervention
by: Xueyan Zhao, et al.
Published: (2023)

Percutaneous closure of patent ductus arteriosus: short term results
by: Yüksel Kaya, et al.
Published: (2013)

Bayesian Networks Advances and Novel Applications
Published: (2019)

Comparative efficacy and safety of various Chinese patent medicines combined with western medicine for adults with insomnia: A Bayesian network meta-analysis of randomized controlled trials
by: Ciyan Peng, et al.
Published: (2023)

Percutaneous closure of patent ductus arteriosus with the Nit-Occlud® patent ductus arteriosus device in 268 consecutive cases
by: Andrii V Maksymenko, et al.
Published: (2019)

Residual Dyslipidemia Leads to Unfavorable Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention
by: Bin Que, et al.
Published: (2016)

Impacts of CYP2C19 Polymorphism and Clopidogrel Dosing on in-Stent Restenosis: A Retrospective Cohort Study in Chinese Patients
by: Zhang M, et al.
Published: (2020)

Factors contributing to exercise tolerance in patients with coronary artery disease undergoing percutaneous coronary intervention
by: Husheng Li, et al.
Published: (2023)

Efficacy and safety of oral Chinese patent medicines in the treatment of coronary heart disease combined with hyperlipidemia: a systematic review and network meta-analysis of 78 trials
by: Zhenyu Yang, et al.
Published: (2023)

Temporal characteristics and associated factors of discontinuation and outcomes after percutaneous coronary intervention
by: Haiyan Xu, et al.
Published: (2024)

Structural characteristics of China's COVID-19 patent cooperation network at the province, city, and patent applicant levels
by: Wei Xia, et al.
Published: (2022)

Targeting the epigenome in in-stent restenosis: from mechanisms to therapy
by: Xi Yang, et al.
Published: (2021)

Nanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis
by: Ivan S. Alferiev, et al.
Published: (2024)

Machine Learning-Based Prediction of In-Stent Restenosis Risk Using Systemic Inflammation Aggregation Index Following Coronary Stent Placement
by: Hou L, et al.
Published: (2024)

Advanced Lung Cancer Inflammation Index for Predicting Prognostic Risk for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Wang X, et al.
Published: (2023)

Comparative Efficacy of Chinese Herbal Injections for the Treatment of Herpangina: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
by: Xiaojiao Duan, et al.
Published: (2020)

Effects of Shenmai injection against chronic heart failure: a meta-analysis and systematic review of preclinical and clinical studies
by: Yang Wu, et al.
Published: (2024)